cross-posted from: https://mander.xyz/post/11304633

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

    • Mikufan@ani.social
      link
      fedilink
      English
      arrow-up
      1
      arrow-down
      1
      ·
      7 months ago

      All would come with the problem that the companys stop investing into research. This would be compensatable by government funded research, but it would be a very large restructuring.

      I think its ok for them to hold patents for some medicine, as long as they sell it for a reasonable price. Those patents however should expire after like 5 years.